Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 53.82% vs -2.00% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -86.82% vs 6.08% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -77.95% vs -7.20% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 30.88% vs 51.11% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Jiangsu Lianhuan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 22.24% vs 3.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 53.82% vs -2.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 107.69% vs -318.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -86.82% vs 6.08% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -69.14% vs -41.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -77.95% vs -7.20% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 5.95% vs 16.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 30.88% vs 51.11% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






